TY - JOUR
T1 - Dynamic Structure and Inhibition of a Malaria Drug Target
T2 - Geranylgeranyl Diphosphate Synthase
AU - Ricci, Clarisse G.
AU - Liu, Yi Liang
AU - Zhang, Yonghui
AU - Wang, Yang
AU - Zhu, Wei
AU - Oldfield, Eric
AU - McCammon, J. Andrew
N1 - Publisher Copyright:
© 2016 American Chemical Society.
PY - 2016/9/13
Y1 - 2016/9/13
N2 - We report a molecular dynamics investigation of the structure, function, and inhibition of geranylgeranyl diphosphate synthase (GGPPS), a potential drug target, from the malaria parasite Plasmodium vivax. We discovered several GGPPS inhibitors, benzoic acids, and determined their structures crystallographically. We then used molecular dynamics simulations to investigate the dynamics of three such inhibitors and two bisphosphonate inhibitors, zoledronate and a lipophilic analogue of zoledronate, as well as the enzyme's product, GGPP. We were able to identify the main motions that govern substrate binding and product release as well as the molecular features required for GGPPS inhibition by both classes of inhibitor. The results are of broad general interest because they represent the first detailed investigation of the mechanism of action, and inhibition, of an important antimalarial drug target, geranylgeranyl diphosphate synthase, and may help guide the development of other, novel inhibitors as new drug leads.
AB - We report a molecular dynamics investigation of the structure, function, and inhibition of geranylgeranyl diphosphate synthase (GGPPS), a potential drug target, from the malaria parasite Plasmodium vivax. We discovered several GGPPS inhibitors, benzoic acids, and determined their structures crystallographically. We then used molecular dynamics simulations to investigate the dynamics of three such inhibitors and two bisphosphonate inhibitors, zoledronate and a lipophilic analogue of zoledronate, as well as the enzyme's product, GGPP. We were able to identify the main motions that govern substrate binding and product release as well as the molecular features required for GGPPS inhibition by both classes of inhibitor. The results are of broad general interest because they represent the first detailed investigation of the mechanism of action, and inhibition, of an important antimalarial drug target, geranylgeranyl diphosphate synthase, and may help guide the development of other, novel inhibitors as new drug leads.
UR - http://www.scopus.com/inward/record.url?scp=84987641957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84987641957&partnerID=8YFLogxK
U2 - 10.1021/acs.biochem.6b00398
DO - 10.1021/acs.biochem.6b00398
M3 - Article
C2 - 27564465
AN - SCOPUS:84987641957
SN - 0006-2960
VL - 55
SP - 5180
EP - 5190
JO - Biochemistry
JF - Biochemistry
IS - 36
ER -